| The loss of radiographic enhancement in primary renal cell carcinoma tumors ... - UroToday |
|
|
UroTodayTo characterize radiographic intratumoral contrast enhancement in the primary tumor of patients with renal cell carcinoma treated with either sorafenib or ... read more |